Published in Drug Law Weekly, January 22nd, 2008
"Dr. Cameron is one of the best qualified, effective and commercially astute medics that we know," said Kate Bingham, SVLS Managing Partner, specializing in therapeutic investments. "He has worked in a range of clinical areas at Astra Zeneca and his recent leadership of Cambridge Antibody Technology ("CAT") as Chief Executive Officer will prove invaluable to building and growing successful new therapeutic companies."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.